西子健康港股IPO：高度依赖抖音平台线下渠道仅创收1%、研发投入不足1%、营销投入超成本、多品类生产靠代工

Core Viewpoint - Xizi Health Group has submitted its listing application to the Hong Kong Stock Exchange, aiming to raise funds for brand enhancement, product development, and digital capabilities, despite facing operational risks that may affect its capital journey [1][14]. Financial Performance - Xizi Health's annual revenue increased from 1.447 billion yuan in 2023 to 1.609 billion yuan in the first three quarters of 2025, with gross margin rising from 44.4% to 59.5% over the same period [5][18]. - The company ranks as the third largest player in China's sports nutrition food industry, holding a market share of 4.5% [18]. Sales and Marketing Strategy - The company heavily relies on online sales channels, particularly the Douyin platform, with online revenue accounting for over 95% of total sales [6][19]. - Marketing expenses have surged from approximately 473 million yuan in 2023 to 756 million yuan in the first three quarters of 2025, with the sales expense ratio increasing from 32.7% to 47% [9][22]. Production and Supply Chain - Xizi Health operates a mixed production model, relying on third-party manufacturers for most of its product lines, with only one production facility located in Changsha, Hunan [10][28]. - The company’s production capacity is projected to reach 7 million bags per month by 2025, with utilization rates of 98.69% in 2024 and 81.16% in 2025 [25][26]. Research and Development - R&D expenditures are minimal, with rates below 1% of revenue, indicating a significant focus on marketing over product innovation [15][22]. - R&D spending for 2023, 2024, and the first three quarters of 2025 was approximately 6.7 million yuan, 12.1 million yuan, and 11.7 million yuan, respectively [13][22]. Risks and Challenges - The company's dependence on Douyin poses systemic risks, as any deterioration in relationships with major e-commerce platforms could adversely affect operations [19][20]. - Xizi Health's reliance on external manufacturers raises concerns about quality control and supply chain stability, which could impact profitability [12][28].